Diabetes and Lipid Problems
Dyslipidemia: What Is It?
Jan 1, 1994 |
Dyslipidemia is abnormal lipid metabolism. It is very common among people with Type 2 diabetes, and most frequently involves increased levels of triglycerides, very low density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol, as well as decreased levels of high-density lipoprotein (HDL). These abnormalities appear to be caused by increased secretion of VLDL particles from the liver due to increased concentrations of free fatty acids and glucose.
Drug Reduces Triglycerides by 26%
Feb 1, 1993 |
In a study from the Eastern Virginia Medical School in Norfolk, the lipid-regulating drug, gem-fibrozil (Lopid), was found to significantly improve triglyceride (blood fat) and high-density lipoprotein (HDL) levels in a group of type 2 diabetes patients. Lipid disorders are a major cause of atherosclerosis (hardening of the arteries), a condition which accounts for the majority of diabetes-related deaths. The ability to control stable lipid levels would greatly reduce the risk of developing heart disease.
Close Encounter - A Profile of a Diabetes Patient and Business Insider
Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54